Portfolio news 0

Hinge Health, Inc.

Hinge Health Brings Personalized Digital MSK Solution to the Global Workforce

Intelligent Ultrasound Group plc

Intelligent Ultrasound Group plc - Audited Results for the Year Ended 31 December 2023

Genomics

Genomics plc and GSK establish precision medicine collaboration to assess polygenic risk scores in clinical trial design

Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies and BugSeq announce collaboration to provide fully automated analysis solutions for rapid pathogen identification and antimicrobial resistance

Ultraleap Ltd

Ultraleap - DPVR Unveils New Headset E4 Arc featuring Ultraleap Hand Tracking

First Light Fusion Ltd

First Light Fusion - First Light Founder moves into new science-focused role with Acting CEO appointed

Kynos Therapeutics Ltd

Kynos Therapeutics announces positive top line results from the first-in-human Phase I study of its KMO inhibitor, KNS366, demonstrating safety, tolerability and target engagement

Pulmocide

Pulmocide Announces Successful Results from the OPERA-S Study: a Phase 2 Safety Study with Inhaled Opelconazole

Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies plc - New nanopore-based research unlocks insights into disease and longevity

Genomics

Genomics plc and MassMutual's program enables more policyowners to understand health risks through innovative genetic testing